Flamel Technologies (NASDAQ: FLML) today announced positive preliminary Phase I results from a trial comparing the safety, tolerability, and long-acting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE